Frenova is the world’s only contract clinical development services provider dedicated exclusively to renal research. As a Fresenius Medical Care North America company, Frenova manages a network of clinical research assets and resources including over 450 principal investigators at more than 260 sites.  Frenova manages clinical trials in kidney disease and its adjacent disease areas and medical conditions.  Frenova offers clinical trial sponsors access to nearly 200,000 end stage renal disease (ESRD) patients and hundreds of thousands of chronic kidney disease (CKD) patients. For more information, visit